期刊文献+

85例次腹膜透析相关性腹膜炎的致病菌及药敏分析 被引量:15

Pathogens and drug sensitivity in peritoneal dialysis-related peritonitis
在线阅读 下载PDF
导出
摘要 目的探讨腹膜透析相关性腹膜炎的致病菌及其对药物的敏感性。方法回顾性分析郑州大学第一附属医院腹膜透析中心2006~2009年间收治的85例次持续不卧床腹膜透析(CAPD)相关性腹膜炎患者的致病菌及药敏试验结果。结果85例次cAPD引流液培养中,58例次(68.2%)培养阳性,致病菌中革兰阳性球菌34例次(58.6%),革兰阴性杆菌18例次(31.1%),真菌6例次(10.3%)。药敏试验结果表明,革兰阳性球菌对头孢唑啉耐药率达61.8%,对万古霉素和亚胺培南的耐药率均为2.9%。革兰阴性杆菌对庆大霉素耐药率达50.0%,对亚胺培南耐药率为5.6%。腹膜炎的退出率为23.5%。结论CAPD相关腹膜炎致病菌仍以革兰阳性球菌为主,但革兰阴性杆菌及真菌所致腹膜炎比例有上升趋势。致病菌对头孢唑啉和庆大霉素的耐药率较高,对亚胺培南和万古霉素的耐药率较低可作为经验用药。 Objective To investigate the pathogens and their drug sensitivity in peritoneal dialysis-related peritonitis. Methods Pathogens and drug susceptibility test results of 85 cases of continuous ambulatory peritoneal dialysis(CAPD)-related peritonitis were analyzed retrospectively. Results Among 85 cases of CAPD drainage fluid culture,58 cases were cultured positive with a positive rate of 68.2%, including 34 cases of gram-positive cocci (58.6 % ), 18 cases of gram-negative bacilli (31.1% ), and 6 cases of fungi (10.3 % ). Drug sensitivity test results showed that gram-positive cocci showed a high resistance rate of 61.8% to cefazolin and a low resistance rate of 2, 9% to vancomycin or imipenem. 50.0% of gram-negative bacilli were resistant to gentamycin. There was a low resistance rate of 5.6% to imipenem. The total CAPD withdrawal rate in peritonitis was 23.5%. Conclusion Gram-positive cocci is still the main pathogen in CAPD related-peritonitis, but there is an increasing proportion of peritonitis caused by gram-negative bacteria and fungal. There is a high resistance rate to cefazolin or gentamycin and a low resistance to vancomycin or imipenem. Therefore, vancomycin and imipenem can be used as empiric therapy for CAPD related peritonitis.
出处 《临床荟萃》 CAS 2010年第5期405-408,共4页 Clinical Focus
关键词 腹膜透析 腹膜炎 细菌 抗菌药 peritoneal dialysis peritonitis bacteria anti-bacterial agents
作者简介 通信作者:赵占正,Email:13938525666@139.com
  • 相关文献

参考文献11

  • 1Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis : best demonstrated practices[J]. Kidney Int Suppl,2006,70(103) :S44-54.
  • 2维持性腹膜透析共识[J].中华肾脏病杂志,2006,22(8):513-516. 被引量:99
  • 3叶应抚,王毓三.全国临床检验操作规程[M].南京:东南大学出版社,1991:165-168.
  • 4倪军,童孟立,崔杏成.72例次持续性非卧床腹透腹膜炎分析[J].中国中西医结合肾病杂志,2007,8(4):217-219. 被引量:24
  • 5董捷.关于2005年ISPD腹膜透析相关感染诊治指南的几点思考[J].中国血液净化,2008,7(3):117-119. 被引量:7
  • 6Santoianni JE,Predari SC,Veron D,et al. A 15 year-review of peritoneal dialysis-related peritonitis: microbiological trends and patterns of infection in a teaching hospital in Argentina [J]. Rev Argent Microbiol,2008,40(1) :17-23.
  • 7Piraino B. Insight on peritoneal dialysis-related infections[J]. Contrib Nephrol Epuh, 2009,16(3) : 161-168.
  • 8Shemin D. Gram negative rod peritonitis in peritoneal dialysis [J]. Semin Dial, 1997,10(1) :38-45.
  • 9Wiggins KJ, Craig JC, Johnson DW, et al. Treatment of peritoneal dialysis-associated peritonitis:a systematic review of randomized controlled trials[J]. Am J Kidney Dis, 2007, 50 (6) :967-988.
  • 10韩庆烽,汪涛.腹膜透析相关性腹膜炎[J].中国血液净化,2007,6(12):642-644. 被引量:39

二级参考文献27

  • 1傅鹏,董燕,袁伟杰,于建平,崔若兰.腹膜透析患者退出原因分析及处理[J].中国血液净化,2002,1(4):14-16. 被引量:9
  • 2Figueiredo AE,Poli de Figueiredo CE,D′Avila DO.Bag exchange in continuous ambulatory peritoneal dialysis without use of a face mask:experience of five year.Adv Perit Dial,2001,17:98-100.
  • 3Li PK,Law MC,Chow KM,et al.Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis:a prospective,randomized,controlled multicenter study.Am J Kidney Dis,2002,40(2):373-380.
  • 4Kim DK,Yoo TH,Ryu DR,et al.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis:a single center's experience over one decade.Perit Dial Int,2004,24(5):424-432.
  • 5Port FK,Held PJ,Nolph KD,et al.Risk of peritonitis and technique failure by CAPD connection technique:a national study.Kidney Int,1992,42(4):967-974.
  • 6Khairullah Q,Provenzano R,Tayeb J,et al.Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.Perit Dial Int,2002,22(3):339-344.
  • 7Coffin E,Pouthier D,Pochet JM,et al.Vancomycin and ciprofloxacin:systemic adtibiotic administration for peritoneal dialysis-associated peritonitis.Perit Dial Int,2004,24(5):416-418.
  • 8Kavanagh D,Prescott GJ,Mactier RA.Peritoneal dialysis-associated peritonitis in Scotland(1999-2002).Nephrol Dial Transplant,2004,19(10):2584-2591.
  • 9Bender FH,Bernardini J,Piraino B.Prevention of infectious complications in peritoneal dialysis:best demonstrated practices.Kidney Int Suppl,2006,(103):S44-54.
  • 10Piraino B,Bailie GR,Bernardini J,et al.Peritoneal dialysis-related infections recommendations:2005 update.Perit Dial Int,2005,25(2):107-131.

共引文献159

同被引文献128

引证文献15

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部